Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HORWITZ

Showing results (651-660 of 831) with videos related to

Pageof 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative ProjectYoun H Kim, Mahkam Tavallaee, Uma Sundram, et al.
Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Archives of Pathology & Laboratory Medicine|April 26, 2022
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel ConsensusAlejandro A Gru, Megan S Lim, Ahmet Dogan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2020
Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate CancerVladimir Avkshtol, Karen J Ruth, Eric A Ross, et al.
Cancer Research|April 15, 2010
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapyGiulia Grisendi, Rita Bussolari, Luigi Cafarelli, et al.
Blood Cancer Journal|May 22, 2019
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapseAnita Kumar, Fushen Sha, Ahmed Toure, et al.
Blood Advances|April 10, 2019
Targeting CD47 in Sézary syndrome with SIRPαFcLisa D S Johnson, Swati Banerjee, Oleg Kruglov, et al.
Blood Advances|June 13, 2025
BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implantsPaola Ghione, Diana Mandelker, Maria E Arcila, et al.
Pageof 84

Showing results (651-660 of 831) with videos related to

Sort By:
Pageof 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative ProjectYoun H Kim, Mahkam Tavallaee, Uma Sundram, et al.
Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Archives of Pathology & Laboratory Medicine|April 26, 2022
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel ConsensusAlejandro A Gru, Megan S Lim, Ahmet Dogan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2020
Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate CancerVladimir Avkshtol, Karen J Ruth, Eric A Ross, et al.
Cancer Research|April 15, 2010
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapyGiulia Grisendi, Rita Bussolari, Luigi Cafarelli, et al.
Blood Cancer Journal|May 22, 2019
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapseAnita Kumar, Fushen Sha, Ahmed Toure, et al.
Blood Advances|April 10, 2019
Targeting CD47 in Sézary syndrome with SIRPαFcLisa D S Johnson, Swati Banerjee, Oleg Kruglov, et al.
Blood Advances|June 13, 2025
BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implantsPaola Ghione, Diana Mandelker, Maria E Arcila, et al.
Pageof 84